Neuropathic pain: molecular complexity underlies continuing unmet medical need.
Kennedy
Jeffrey D
JD
Neuroscience Discovery, Wyeth Research, CN 8000, Princeton, New Jersey 08543-8000, USA. kennedj2@wyeth.com
D000200:Action Potentials; D000208:Acute Disease; D000818:Animals; D002908:Chronic Disease; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D015640:Ion Channel Gating; D007473:Ion Channels / Q000502:physiology; D008564:Membrane Potentials; D009473:Neuronal Plasticity; D018377:Neurotransmitter Agents / Q000378:metabolism; D009619:Nociceptors / Q000502:physiology; D010146:Pain / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D015398:Signal Transduction
D007473:Ion Channels; D018377:Neurotransmitter Agents